Petvivo Holdings Stock Price, News & Analysis

Welcome to our dedicated page for Petvivo Holdings news (Ticker: PETVW), a resource for investors and traders seeking the latest updates and insights on Petvivo Holdings stock.

PetVivo Holdings, Inc. (warrants trading as PETVW alongside common stock PETV on OTCQX) generates a steady flow of news around its role as an emerging biomedical device company in the companion animal and equine markets. Company releases highlight developments in its veterinary medical devices and therapeutics, AI-powered platforms, distribution partnerships and corporate governance, providing context for investors and veterinary professionals following the PETVW warrants.

Recent news has focused on SPRYNG® with OsteoCushion® technology and PrecisePRP®, PetVivo’s lead products for managing joint-related conditions and musculoskeletal restoration in cats, dogs and horses. Articles describe clinical adoption, distributor expansion, continuing education initiatives for veterinarians and collaborations with equine-focused partners that integrate these products into care protocols.

Another major news theme is the company’s move into artificial intelligence through PetVivo AI, Inc. and the PetVivo.ai platform. Press releases detail an exclusive 10-year licensing agreement for the Agentic Pet AI framework, beta testing results, and the launch of a two-sided ecosystem that uses specialized AI agents to reduce veterinary client acquisition costs and connect practices with engaged pet parents. Additional coverage discusses technical validation of the framework via a published whitepaper and the release of a video explainer for PetVivo.ai.

News items also cover earnings announcements, conference calls and investor presentations, as well as board changes such as the appointment of an independent director. For anyone tracking PETVW, this news page offers a centralized view of PetVivo’s operational updates, product milestones, AI initiatives and strategic partnerships. Investors and observers can review these articles to understand how the company’s veterinary devices, regenerative products and AI platforms are being positioned in the animal health market.